financetom
Business
financetom
/
Business
/
GE Vernova to supply turbines by 2026 for planned natgas power plant in Pennsylvania
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GE Vernova to supply turbines by 2026 for planned natgas power plant in Pennsylvania
Apr 2, 2025 11:15 AM

April 2 (Reuters) - GE Vernova ( GEV ) will aid in turning Homer City Generating Station

- previously a coal-power plant in Pennsylvania - into a natural gas-powered data center campus

by providing seven turbines to produce nearly 4.5 gigawatts (GW) of power.

The project is expected to begin producing power by 2027. Once complete, it would be the

largest natural gas power plant in the U.S., surpassing NextEra Energy's main utility, Florida

Power & Light's West County Energy Center, which has a capacity of nearly 3.8 GW, according to

data from the U.S. Energy Information Administration.

In a release on Wednesday from Homer City Redevelopment (HCR), which is in charge of the

project, it said that construction of the site is expected to begin this year, and GE Vernova ( GEV )

will supply the turbines by 2026.

Energy-intensive data centers needed to scale artificial intelligence technologies are

expected to push up demand for gas turbines used in large-scale power generation projects.

U.S. natural gas use is set to continue hitting record highs due in part from this demand,

but a lack of infrastructure could hurt the industry.

Knighthead Capital Management, which has had significant equity positions in Homer City for

nearly eight years, will continue to lead the project financing, HCR added, with an initial

capital investment being expected to exceed $10 billion for power infrastructure and site

readiness.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Jul 17, 2024
08:54 AM EDT, 07/17/2024 (MT Newswires) -- Consumer stocks were leaning lower pre-bell Wednesday, with the Consumer Staples Select Sector SPDR Fund (XLP) marginally declining and the Consumer Discretionary Select Sector SPDR Fund (XLY) recently down 0.7%. VF (VFC) was up more than 10% after saying it entered into a definitive agreement to sell its Supreme brand to EssilorLuxottica for...
Market Chatter: Shoppers Drug Mart Strikes Partnership With Blood Testing Startup Truvian Health
Market Chatter: Shoppers Drug Mart Strikes Partnership With Blood Testing Startup Truvian Health
Jul 17, 2024
08:55 AM EDT, 07/17/2024 (MT Newswires) -- Shoppers Drug Mart has struck a commercial partnership with Truvian Health, a San Diego-based startup that is seeking regulatory approval for its printer-sized devices to conduct on-the-spot blood tests without the need to go to a lab, The Globe and Mail is reporting Wednesday. Loblaw Cos. Ltd. ( LBLCF ) , which owns...
Royal Philips, Bon Secours Mercy Health Launch 10-Year Patient Monitoring Partnership
Royal Philips, Bon Secours Mercy Health Launch 10-Year Patient Monitoring Partnership
Jul 17, 2024
08:54 AM EDT, 07/17/2024 (MT Newswires) -- Royal Philips (PHG) and Bon Secours Mercy Health said Wednesday they have formed a 10-year partnership to support patient monitoring across Bon Secours' 49 hospitals. The companies said the collaboration will utilize Philips' monitoring technology to integrate patient data, offering BSMH clinicians improved insights and reducing their digital workload. The initial three years...
InMode Says FDA Clears Morpheus8 Technology for Soft Tissue Contraction
InMode Says FDA Clears Morpheus8 Technology for Soft Tissue Contraction
Jul 17, 2024
08:58 AM EDT, 07/17/2024 (MT Newswires) -- InMode ( INMD ) said Wednesday it has received an additional US Food and Drug Administration's clearance for Morpheus8, a fractional radiofrequency microneedling technology for soft tissue contraction. The regulator cleared the Morpheus8 applicators for fractional radiofrequency use in dermatologic skin procedures where coagulation/contraction of soft tissue or hemostasis is required, the medical...
Copyright 2023-2026 - www.financetom.com All Rights Reserved